Isolated ileal interposition in enteroendocrine L cells differentiation
Isolated ileal interposition in enteroendocrine L cells differentiation
Isolated ileal interposition in enteroendocrine L cells differentiation
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Nature Preced<strong>in</strong>gs : doi:10.1038/npre.2011.6614.2 : Posted 30 Nov 2011<br />
14. Mokdad AH, Ford ES, Bowman BA, Dietz WH, V<strong>in</strong>icor F, Bales VS, Marks JS. Prevalence<br />
of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA-J Am Med Assoc.<br />
2003;289(1):76-9.<br />
15. Freeman JS. New therapeutic options: management strategies to optimize glycemic<br />
control. J Am Osteopath Assoc. 2010;110(3Suppl2):S15-20.<br />
16. Blonde L. Current antihyperglycemic treatment guidel<strong>in</strong>es and algorithms for patients<br />
with type 2 diabetes mellitus. Am J Med. 2010;123(3):S12-8.<br />
17. Stolar MW, Hoogwerf BJ, Boyle PJ, Gorshow SM, Wales D. Manag<strong>in</strong>g type 2 diabetes:<br />
go<strong>in</strong>g beyond glycemic control. J Manag Care Pharm. 2008;14(5SupplB): S2-19. Available at:<br />
http://www.amcp.org/data/jmcp/JMCPSuppBJune08Web.pdf<br />
18. Krentz AJ, Patel MB, Bailey CJ. New drugs for type 2 diabetes mellitus: what is their<br />
place <strong>in</strong> therapy? Drugs. 2008;68(15):2131-62.<br />
19. VanDeKoppel S, Choe H, Sweet B. Managed care perspective on three new agents for<br />
type 2 diabetes. J Manag Care Pharm. 2008;14(4):363-80.<br />
20. V<strong>in</strong>ik A. Advanc<strong>in</strong>g therapy <strong>in</strong> type 2 diabetes mellitus with early, comprehensive<br />
progression from oral agents to <strong>in</strong>sul<strong>in</strong> therapy. Cl<strong>in</strong> Ther. 2007;29(6):1236-53.<br />
21. Del Prato S. Unlock<strong>in</strong>g the opportunity of tight glycaemic control. Diabetes Obes<br />
Metab. 2005;7:S1-4.<br />
22. Fleury-Milfort E. Practical strategies to improve treatment of type 2 diabetes. J Am<br />
Acad Nurse Pract. 2008;20(6):295-304.<br />
23. Liebl A. Challenges <strong>in</strong> optimal metabolic control of diabetes. Diabetes Metab Res Rev.<br />
2002;18(S3):S36-41.<br />
24. Kunt T, Snoek F. Barriers to <strong>in</strong>sul<strong>in</strong> <strong>in</strong>itiation and <strong>in</strong>tensification and how to overcome<br />
them. Int J Cl<strong>in</strong> Pract. 2009;63:6-10.<br />
25. He<strong>in</strong>emann L. Overcom<strong>in</strong>g obstacles: new management options. Eur J Endocr<strong>in</strong>ol.<br />
2004;151(2):T23-7.<br />
26. Brunton S. Beyond glycemic control: treat<strong>in</strong>g the entire type 2 diabetes disorder.<br />
Postgrad Med. 2009;121(5):68-81.<br />
27. Peters AL. Patient and treatment perspectives: Revisit<strong>in</strong>g the l<strong>in</strong>k between type 2<br />
diabetes, weight ga<strong>in</strong>, and cardiovascular risk. Clev Cl<strong>in</strong> J Med. 2009;76(5):S20-7.<br />
28. Hansen KB, Vilsboll T, Knop FK. Incret<strong>in</strong> mimetics: a novel therapeutic option for<br />
patients with type 2 diabetes – a review. Diabetes Metab Syndr Obes. 2010;3:155-63.<br />
29. Czupryniak L, Wiszniewski M, Szyma ski D, Paw owski M, Loba J, Strzelczyk J. Long-term<br />
results of gastric bypass surgery <strong>in</strong> morbidly obese type 1 diabetes patients. Obes Surg.<br />
2010;20(4):506-8.<br />
30. Rub<strong>in</strong>o F, Gagner M. Potential of surgery for cur<strong>in</strong>g type 2 diabetes mellitus. Ann Surg.<br />
2002;236(5):554-9.<br />
31. Buchwald H, Avidor Y, Braunwald E. Bariatric Surgery: A Systematic Review. JAMA-J Am<br />
Med Assoc. 2004;292(14):1724-37.<br />
32. Santry HP, Gillen DL, Lauderdale DS. Trends <strong>in</strong> bariatric surgical procedures. Jama.<br />
2005;294(15):1909-17.<br />
33. van de Sande-Lee S, Pereira FRS, C<strong>in</strong>tra DE, Fernandes PT, Cardoso AR,<br />
Garlipp CR, Chaim EA, Pareja JC, Geloneze B, Li LM, Cendes F, Velloso LA. Partial reversibility of<br />
hypothalamic dysfunction and changes <strong>in</strong> bra<strong>in</strong> activity after body mass reduction <strong>in</strong> obese<br />
subjects. Diabetes. 2011;60(6):1699-704.<br />
34. Meijer RI, van Wagensveld BA, Siegert CE, Er<strong>in</strong>ga EC, Serne EH, Smulders YM. Bariatric<br />
surgery as a novel treatment for type 2 diabetes mellitus: a systematic review. Arch Surg.<br />
2011;146(6):744-50.<br />
35. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA,<br />
deRamon RA, Israel G, Dolezal JM, Dohm L. Who would have thought it? An operation proves<br />
to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339-<br />
50.